Estimated pulse wave velocity in metabolic dysfunction‐associated steatotic liver disease and all‐cause/cause‐specific mortality

Documenti analoghi

• The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
  di: Brandon J. Perumpail, et al.
  Pubblicazione: (2024)
• Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States
  di: Donghee Kim, et al.
  Pubblicazione: (2024)
• Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
  di: Yi‐Ting Chen, et al.
  Pubblicazione: (2024)
• Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
  di: Kazuma Mori, et al.
  Pubblicazione: (2024)
• Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility
  di: Connor Henry‐Blake, et al.
  Pubblicazione: (2024)